A glycolipid adjuvant 7DW8-5 for malaria vaccines
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93023C00041
- Awardee
-
The Trustees Of Columbia University In The City Of New York UEI QHF5ZZ114M72 Part of The Trustees Of Columbia University In The City Of New York
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,501,040
Award facts
- Opportunity
-
- 75N93022R00009 Solicitation number
- Contract value 100% obligated
- $2,501,040.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 24 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10032, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,089,350 | |
| Original award | $1,411,690 |
About this award
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract is for the development of a glycolipid adjuvant called 7DW8-5 to be used in malaria vaccines. The contract has a ceiling value of $2,501,040.00 and a completion date of September 29, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. Columbia University has a strong track record of federal contract and grant awards, including work with the Centers for Disease Control and Prevention (CDC), National Heart, Lung, and Blood Institute (NHLBI), and U.S. Army Engineer Research and Development Center (ERDC), covering a range of research areas such as epidemiological studies, vaccine safety assessments, and cold cultivation culturomics.
Quick answers
Who was awarded contract 75N93023C00041?
75N93023C00041 was awarded to The Trustees Of Columbia University In The City Of New York by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2023.
How much is contract 75N93023C00041 worth?
The government has obligated $2,501,040 on 75N93023C00041.
Was contract 75N93023C00041 competed?
The extent of competition for 75N93023C00041 was full and open competition. The government received 24 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award